More recently, Han et al. [59] revealed that empagliflozin-mediated attenuation of aortic atheroma volume in Apo E-deficient mice was associated with reduced insulin resistance, a reduction in the levels of inflammatory markers, and increased adiponectin. Here, ADIPOQ is linked to Insulin resistance.